Sex Moderates the Impact of Diagnosis and Amyloid PET Positivity on Hippocampal Subfield Volume

J Alzheimers Dis. 2018;64(1):79-89. doi: 10.3233/JAD-180028.

Abstract

We examined moderation effects of sex and diagnosis on the effect of positive florbetapir positron emission tomography (PET) amyloid-β (Aβ) scan (A+) on hippocampus subfield volumes in 526 normal control (NC) and early mild cognitive impairment (eMCI) participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI2; ADNI-GO). Regression moderation models showed that women- but not men- with NC designation did not show reduced subiculum volumes despite A+. At the eMCI stage, A+ was detrimental across sexes. Findings were significant while accounting for the effects of age, cognition at screening, education, and APOE4 carrier status. These findings suggest that women with A+ have early neural resistance to Alzheimer's disease-related amyloid burden.

Keywords: Alzheimer’s disease; amyloid; magnetic resonance imaging; memory; mild cognitive impairment; positron emission tomography.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnostic imaging*
  • Alzheimer Disease / genetics
  • Aniline Compounds / pharmacokinetics
  • Apolipoproteins E / genetics
  • Ethylene Glycols / pharmacokinetics
  • Female
  • Hippocampus / diagnostic imaging*
  • Hippocampus / drug effects
  • Humans
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Neuropsychological Tests
  • Positron-Emission Tomography
  • Sex Characteristics*
  • Statistics, Nonparametric

Substances

  • Aniline Compounds
  • Apolipoproteins E
  • Ethylene Glycols
  • florbetapir